-
1
-
-
68149180722
-
Recent developments in Clopidogrel pharmacology and their relation to clinical outcomes
-
Gurbel PA, Antonino MJ, Tantry US. Recent developments in Clopidogrel pharmacology and their relation to clinical outcomes. Expert Opin Drug Metab Toxicol 2009;5:989-1004.
-
(2009)
Expert Opin Drug Metab Toxicol
, vol.5
, pp. 989-1004
-
-
Gurbel, P.A.1
Antonino, M.J.2
Tantry, U.S.3
-
2
-
-
77953914877
-
Genotyping: One piece of the puzzle to personalize antiplatelet therapy
-
Gurbel PA, Tantry US, Shuldiner AR, Kereiakes DJ. Genotyping: one piece of the puzzle to personalize antiplatelet therapy. J Am Coll Cardiol 2010,56:112-6.
-
(2010)
J Am Coll Cardiol
, vol.56
, pp. 112-116
-
-
Gurbel, P.A.1
Tantry, U.S.2
Shuldiner, A.R.3
Kereiakes, D.J.4
-
3
-
-
41249093357
-
At al. Adjusted Clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with Clopidogrel resistance: A multicenter randomized prospective study
-
Bonello L, Camoin-Jau L, Arques S, Boyer C, Panagides D, Wittenberg O, at al. Adjusted Clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with Clopidogrel resistance: a multicenter randomized prospective study. J Am Coll Cardiol 2008;51:1404-11.
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 1404-1411
-
-
Bonello, L.1
Camoin-Jau, L.2
Arques, S.3
Boyer, C.4
Panagides, D.5
Wittenberg, O.6
-
4
-
-
35549008493
-
Platelet function monitoring in patients with coronary artery disease
-
Gurbel PA, Becker RC, Mann KG, Steinhubl SR, Michelson AD. Platelet function monitoring in patients with coronary artery disease. J Am Coll Cardiol 2007;50:1822-34.
-
(2007)
J Am Coll Cardiol
, vol.50
, pp. 1822-1834
-
-
Gurbel, P.A.1
Becker, R.C.2
Mann, K.G.3
Steinhubl, S.R.4
Michelson, A.D.5
-
5
-
-
58749090547
-
Genetic determinants of response to Clopidogrel and cardiovascular events
-
Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, Meneveau N, et al. Genetic determinants of response to Clopidogrel and cardiovascular events. N Engl J Med 2009;360:363-75.
-
(2009)
N Engl J Med
, vol.360
, pp. 363-375
-
-
Simon, T.1
Verstuyft, C.2
Mary-Krause, M.3
Quteineh, L.4
Drouet, E.5
Meneveau, N.6
-
6
-
-
35048825671
-
Platelet function testing and cardiovascular outcomes: Steps forward in identifying the best predictive measure
-
DOI 10.1160/TH07-08-0518
-
Angiolillo DJ and Alfonso F. Platelet function testing and cardiovascular outcomes: steps forward in identifying the best predictive measure. Thromb Haemost 2007;98:707-9. (Pubitemid 47555058)
-
(2007)
Thrombosis and Haemostasis
, vol.98
, Issue.4
, pp. 707-709
-
-
Angiolillo, D.J.1
Alfonso, F.2
-
7
-
-
77955416969
-
Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic Clopidogrel therapy
-
Sibbing D, Gebhard D, Koch W, Braun S, Stegherr J, Morath T, at al. Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic Clopidogrel therapy. J Thromb Haemost 2010;8:1685-93.
-
(2010)
J Thromb Haemost
, vol.8
, pp. 1685-1693
-
-
Sibbing, D.1
Gebhard, D.2
Koch, W.3
Braun, S.4
Stegherr, J.5
Morath, T.6
-
8
-
-
67649370752
-
Relation of genetic polymorphisms in the cytochrome P450 gene with Clopidogrel resistance after drug-eluting stent implantation in Koreans
-
Lee JM, Park S, Shin DJ, Choi D, Shim CY, Ko YG, at al. Relation of genetic polymorphisms in the cytochrome P450 gene with Clopidogrel resistance after drug-eluting stent implantation in Koreans. Am J Cardiol 2009;104:46-51.
-
(2009)
Am J Cardiol
, vol.104
, pp. 46-51
-
-
Lee, J.M.1
Park, S.2
Shin, D.J.3
Choi, D.4
Shim, C.Y.5
Ko, Y.G.6
-
9
-
-
58249135635
-
Cytochrome P450 2C19 polymorphism in young patients treated with Clopidogrel after myocardial infarction: A cohort study
-
Collet JP, Hulot JS, Pena A, VTllard E, Esteve JB, Silvain J, at al. Cytochrome P450 2C19 polymorphism in young patients treated with Clopidogrel after myocardial infarction: a cohort study. Lancet 2009;373:309-17.
-
(2009)
Lancet
, vol.373
, pp. 309-317
-
-
Collet, J.P.1
Hulot, J.S.2
Pena, A.3
Vtllard, E.4
Esteve, J.B.5
Silvain, J.6
-
10
-
-
1242315475
-
Frequency of nonresponse antiplatelet activity of Clopidogrel during pretreatment for cardiac catheterization
-
Mobley JE, Bresee SJ, Wortham DC, Craft RM, Snider CC, Carroll RC. Frequency of nonresponse antiplatelet activity of Clopidogrel during pretreatment for cardiac catheterization. Am J Cardiol 2004; 93:456-8.
-
(2004)
Am J Cardiol
, vol.93
, pp. 456-458
-
-
Mobley, J.E.1
Bresee, S.J.2
Wortham, D.C.3
Craft, R.M.4
Snider, C.C.5
Carroll, R.C.6
-
11
-
-
9644281092
-
Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting
-
DOI 10.1016/j.thromres.2004.07.007, PII S0049384804003858
-
Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramirez C, BarreraRamirez C, Sabaté M, et al. Identification of low responders to a 300-mg Clopidogrel loading dose in patients undergoing coronary stenting. Thromb Res 2005;115:101-8. (Pubitemid 39572762)
-
(2005)
Thrombosis Research
, vol.115
, Issue.1-2
, pp. 101-108
-
-
Angiolillo, D.J.1
Fernandez-Ortiz, A.2
Bernardo, E.3
Ramirez, C.4
Barrera-Ramirez, C.5
Sabate, M.6
Hernandez, R.7
Moreno, R.8
Escaned, J.9
Alfonso, F.10
Banuelos, C.11
Costa, M.A.12
Bass, T.A.13
MacAya, C.14
-
12
-
-
0028044085
-
Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese
-
De Morais SM, Wilkinson GR, Blaisdell J, Meyer UA, Nakamura K, Goldstein JA. Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol Pharmacol 1994;46:594-8. (Pubitemid 24334747)
-
(1994)
Molecular Pharmacology
, vol.46
, Issue.4
, pp. 594-598
-
-
De Morais, S.M.F.1
Wilkinson, G.R.2
Blaisdell, J.3
Meyer, U.A.4
Nakamura, K.5
Goldstein, J.A.6
-
13
-
-
77949297362
-
Which platelet function test is suitable to monitor Clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogreL
-
Bouman HJ, Parlak E, van Werkum JW, Breet NJ, ten Cate H, Hackeng CM, et al. Which platelet function test is suitable to monitor Clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogreL J Thromb Haemost 2010;8:482-8.
-
(2010)
J Thromb Haemost
, vol.8
, pp. 482-488
-
-
Bouman, H.J.1
Parlak, E.2
Van Werkum, J.W.3
Breet, N.J.4
Ten Cate, H.5
Hackeng, C.M.6
-
14
-
-
57849099154
-
Quantitative determination of Clopidogrel active metabolite in human plasma by LC-MS/MS
-
Takahashi M, Pang H, Kawabata K, Farid NA, Kurihara A. Quantitative determination of Clopidogrel active metabolite in human plasma by LC-MS/MS. J Pharm Biomed Anal 2008;48:1219-24.
-
(2008)
J Pharm Biomed Anal
, vol.48
, pp. 1219-1224
-
-
Takahashi, M.1
Pang, H.2
Kawabata, K.3
Farid, N.A.4
Kurihara, A.5
|